Skip to content
10-Q

Quarterly Report

Oncology Institute, Inc. DFPH TOI TOIIW

0001628280-25-025507

← back to feed
Filed
May 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 7, 2025 89.23M sh
Long Term Debt Q1 2025 · Mar 31, 2025 $73.89M
Long Term Debt Q1 2025 · Dec 31, 2024 $93.13M
Current Liabilities Q1 2025 · Mar 31, 2025 $59.54M
Current Liabilities Q1 2025 · Dec 31, 2024 $52.22M
Total Liabilities Q1 2025 · Mar 31, 2025 $158.93M
Total Liabilities Q1 2025 · Dec 31, 2024 $169.13M
Current Assets Q1 2025 · Mar 31, 2025 $106.82M
Current Assets Q1 2025 · Dec 31, 2024 $112.42M
Total Assets Q1 2025 · Mar 31, 2025 $164M
Total Assets Q1 2025 · Dec 31, 2024 $172.72M
Shares Diluted Q1 2025 · Mar 31, 2024 74.23M sh
Capex Q1 2025 · Mar 31, 2024 $610K
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$15.88M
Stockholders Equity Q1 2025 · Mar 31, 2024 $41.3M
Stockholders Equity Q1 2025 · Dec 31, 2023 $57.03M
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.22
Eps Basic Q1 2025 · Mar 31, 2024 −$0.22
Sga Expense Q1 2025 · Mar 31, 2024 $28.45M
Net Income Q1 2025 · Mar 31, 2024 −$19.89M
Operating Income Q1 2025 · Mar 31, 2024 −$17.97M
Revenue Q1 2025 · Mar 31, 2024 $94.67M